Increase/Decrease in Cash: The total change in cash for the company over the given period.
Protara Therapeutics, Inc. (TARA) had Increase/Decrease in Cash of $-34.92M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-17.78M |
|
-- |
|
-- |
|
$19.63M |
|
$-19.63M |
|
$1.85M |
|
$-17.78M |
|
$-17.78M |
|
$-17.78M |
|
$-17.78M |
|
$-17.78M |
|
$-17.78M |
|
$-19.63M |
|
$-19.45M |
|
57.54M |
|
57.54M |
|
$-0.31 |
|
$-0.31 |
|
| Balance Sheet Financials | |
$140.00M |
|
$0.67M |
|
$51.93M |
|
$191.92M |
|
$8.92M |
|
-- |
|
$1.79M |
|
$10.71M |
|
$181.21M |
|
$181.21M |
|
$181.21M |
|
55.06M |
|
| Cash Flow Statement Financials | |
$-21.34M |
|
$-14.72M |
|
$1.14M |
|
$50.40M |
|
$15.48M |
|
|
Increase/Decrease in Cash |
$-34.92M |
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.69 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-21.34M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-9.81% |
|
-9.81% |
|
-9.27% |
|
-9.81% |
|
$3.29 |
|
$-0.37 |
|
$-0.37 |
|